Cargando…
Remaining Questions about Clinical Variola Major
After the recent summary of World Health Organization–authorized research on smallpox, several clinical issues remain. This policy review addresses whether early hemorrhagic smallpox is disseminated intravascular coagulation and speculates about the cause of the high mortality rate among pregnant wo...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377426/ https://www.ncbi.nlm.nih.gov/pubmed/21470458 http://dx.doi.org/10.3201/eid1704.101960 |
_version_ | 1782235955541835776 |
---|---|
author | Lane, J. Michael |
author_facet | Lane, J. Michael |
author_sort | Lane, J. Michael |
collection | PubMed |
description | After the recent summary of World Health Organization–authorized research on smallpox, several clinical issues remain. This policy review addresses whether early hemorrhagic smallpox is disseminated intravascular coagulation and speculates about the cause of the high mortality rate among pregnant women and whether ocular smallpox is partly the result of trachoma or vitamin A deficiency. The joint destruction common in children with smallpox might be prevented by antiviral drugs, but intraarticular infusion of antiviral drugs is unprecedented. Development of highly effective antiviral drugs against smallpox raises the issue of whether postexposure vaccination can be performed without interference by an antiviral drug. Clinicians should consider whether patients with smallpox should be admitted to general hospitals. Although an adequate supply of second-generation smallpox vaccine exists in the United States, its use is unclear. Finally, political and ethical forces suggest that destruction of the remaining stocks of live smallpox virus is now appropriate. |
format | Online Article Text |
id | pubmed-3377426 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-33774262012-06-20 Remaining Questions about Clinical Variola Major Lane, J. Michael Emerg Infect Dis Policy Review After the recent summary of World Health Organization–authorized research on smallpox, several clinical issues remain. This policy review addresses whether early hemorrhagic smallpox is disseminated intravascular coagulation and speculates about the cause of the high mortality rate among pregnant women and whether ocular smallpox is partly the result of trachoma or vitamin A deficiency. The joint destruction common in children with smallpox might be prevented by antiviral drugs, but intraarticular infusion of antiviral drugs is unprecedented. Development of highly effective antiviral drugs against smallpox raises the issue of whether postexposure vaccination can be performed without interference by an antiviral drug. Clinicians should consider whether patients with smallpox should be admitted to general hospitals. Although an adequate supply of second-generation smallpox vaccine exists in the United States, its use is unclear. Finally, political and ethical forces suggest that destruction of the remaining stocks of live smallpox virus is now appropriate. Centers for Disease Control and Prevention 2011-04 /pmc/articles/PMC3377426/ /pubmed/21470458 http://dx.doi.org/10.3201/eid1704.101960 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Policy Review Lane, J. Michael Remaining Questions about Clinical Variola Major |
title | Remaining Questions about Clinical Variola Major |
title_full | Remaining Questions about Clinical Variola Major |
title_fullStr | Remaining Questions about Clinical Variola Major |
title_full_unstemmed | Remaining Questions about Clinical Variola Major |
title_short | Remaining Questions about Clinical Variola Major |
title_sort | remaining questions about clinical variola major |
topic | Policy Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377426/ https://www.ncbi.nlm.nih.gov/pubmed/21470458 http://dx.doi.org/10.3201/eid1704.101960 |
work_keys_str_mv | AT lanejmichael remainingquestionsaboutclinicalvariolamajor |